Regardless of pemphigus subtype, autoantibody titre negativity at clinical remission in patients classified based on their anti‐Dsg1 and anti‐Dsg3 profile at diagnosis and BSA were useful tools in predicting relapse. Here, DSG3 is linked to pemphigus.